You're Taking Vitamin K2 and Still Deficient. Here's Why.

Your VDR gene encodes the vitamin D receptor, a protein that sits on the surface of your cells and acts as a gatekeeper for fat-soluble vitamins like vitamin K2. When vitamin K2 circulates in your blood, the VDR receptor helps determine whether your cells will accept it and put it to work. VDR also regulates calcium and phosphate homeostasis, which is critical for the bone mineralization that K2 supports.

The BsmI, FokI, and TaqI variants in VDR are common. Roughly 30 to 50 percent of people carry at least one variant, and some carry multiple. Certain VDR variants reduce your cells’ sensitivity to vitamin K2 and other fat-soluble signals, meaning K2 may circulate freely but never actually enter the cells that need it. You can have adequate K2 in your blood and still be functionally deficient at the tissue level.

This is why you might feel that K2 supplementation isn’t working: your intestines absorbed it fine, but your cells’ doors are partially closed. You’re not missing K2; your cells are missing the receptor sensitivity to use it. Over time, this contributes to poor bone density, arterial calcification, and tooth problems despite supplementing.

MTHFR is the enzyme that converts folate into its active form, 5-methyltetrahydrofolate, which fuels your methylation cycle. The methylation cycle is the central hub of cellular energy, detoxification, and nutrient activation. Vitamin K2 relies on a healthy methylation cycle for its activation and recycling. Without adequate methylation, even well-absorbed K2 cannot be fully processed into the active forms your bones and vessels need.

The C677T variant, carried by roughly 40 percent of people with European ancestry, reduces MTHFR enzyme efficiency by 40 to 70 percent. The A1298C variant is also common. These variants create a functional folate and methylation deficit that cascades through your entire nutrient metabolism, including K2 activation. You can eat perfect K2 and have normal blood K2 levels while your cells struggle to process it.

You may experience bone loss despite supplementing K2, poor wound healing, brain fog, or persistent fatigue. These are signs that your methylation cycle is struggling. K2 supplementation alone won’t fix this; you need to restore methylation function first.

BCMO1 converts beta-carotene from plant sources into retinol, the active form of vitamin A. Vitamin A and vitamin K2 share the same absorption and transport pathways, and vitamin A is required for the production of osteocalcin, the protein that K2 activates in bone. If you cannot efficiently convert plant carotenoids to vitamin A, your K2 will also struggle to be transported and utilized.

The R267S and A379V variants in BCMO1 are carried by roughly 45 percent of people. These variants reduce your ability to convert plant-based beta-carotene to retinol by up to 50 percent, creating a secondary deficiency that interferes with K2-dependent bone mineralization. Even if your K2 status is adequate, poor vitamin A status will block K2 from doing its job.

You may notice weak tooth enamel, poor bone healing, or accelerated bone loss despite K2 and calcium supplementation. These are signs that K2 is present but vitamin A deficiency is preventing osteocalcin production. K2 alone won’t fix this.

The GC gene encodes VDBP, the protein that binds and transports vitamin D in your blood. VDBP also transports other fat-soluble vitamins, including vitamin K2. VDBP acts as a shuttle: it picks up vitamins from your intestines and liver and delivers them to tissues throughout your body. How much of your K2 reaches your bones and arteries depends partly on your VDBP variant.

GC has three major haplotypes: 1s, 1f, and 2. These are common across populations. Some GC haplotypes bind vitamin K2 more tightly, leaving less of it available in a free, biologically active form that tissues can actually use. You may have adequate K2 circulating in your blood, but it’s locked in bound form and unavailable to your bones and vessels.

This is why two people with identical K2 intake can have very different K2 status. One person’s VDBP releases K2 freely; the other’s VDBP holds onto it. Over time, the person with the binding-tight variant develops poor bone density and arterial calcification despite adequate K2 supplementation.

SLC23A1 is a transporter protein that actively pumps vitamin C into your cells. Vitamin C is essential for collagen synthesis, the structural protein in bone and connective tissue. Vitamin K2 activates osteocalcin, which binds calcium in the bone matrix, but that matrix is made of collagen. Without adequate intracellular vitamin C, collagen is weak and K2 cannot mineralize it properly.

SLC23A1 variants are carried by roughly 20 to 30 percent of people. These variants reduce intracellular vitamin C transport by up to 50 percent, creating a functional vitamin C deficiency inside your cells even if blood vitamin C looks adequate. Your bones become deficient in both the structural matrix (from poor collagen) and the mineral density (from K2 struggling without adequate vitamin C support).

You may experience slow wound healing, weak tooth enamel, joint pain, or accelerated bone loss despite K2 and calcium supplementation. These are signs that your collagen is not being synthesized or maintained properly. K2 and calcium cannot mineralize weak collagen effectively.

The FUT2 gene encodes a fucosyltransferase enzyme that determines whether you secrete ABO antigens into your saliva and digestive tract. This seemingly minor difference has profound effects on your gut microbiome composition. Your microbiome produces a significant portion of your dietary vitamin K2. If your microbiome composition is unfavorable due to FUT2 status, you lose this endogenous K2 production.

FUT2 has two main variants: secretor (Se) and non-secretor (se). Roughly 20 percent of people are non-secretors. Non-secretors have a fundamentally different microbiome that produces less vitamin K2 and is more prone to dysbiosis, meaning you may be deficient in K2 production from your gut regardless of dietary intake. Non-secretors also have impaired absorption of some fat-soluble vitamins because their microbiome composition affects bile acid metabolism.

You may notice that you feel better on higher K2 supplementation, that fermented foods don’t seem to help much, and that your digestion is sluggish. These are signs of microbiome dysbiosis related to FUT2 status. Dietary K2 alone may never be sufficient; you need supplemental K2 and microbiome support.